Up-regulation of the ubiquitous alternative splicing factor Tra2β causes inclusion of a germ cell-specific exon

Human Molecular Genetics

Volumn 14, Issue 16, 2005, Pages 2289-2303

  Venables, Julian P ^a   Bourgeois, Cyril F ^b   Dalgliesh, Caroline ^a   Kister, Liliane ^b   Stevenin, James ^b   Elliott, David J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GREEN FLUORESCENT PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HYBRID PROTEIN; MESSENGER RNA PRECURSOR; PROTEIN KINASE; PROTEIN P40; PROTEIN TRA2BETA; PURINE; RNA; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL FRACTIONATION; CELL MATURATION; CONTROLLED STUDY; DATA ANALYSIS; DOWN REGULATION; EXON; FLUORESCENCE ACTIVATED CELL SORTING; FLY; GENE MUTATION; GENETIC CONSERVATION; GENETIC REGULATION; GENETIC TRANSFECTION; GERM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; SEX DETERMINATION; SPERMATOGENESIS; TESTIS; TISSUE SPECIFICITY; TITRIMETRY; UPREGULATION;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; DRUG RESISTANCE, MULTIPLE; EXONS; GREEN FLUORESCENT PROTEINS; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; PROTEIN-SERINE-THREONINE KINASES; RNA-BINDING PROTEINS; SPERMATOGENESIS; TESTIS; UP-REGULATION;

EID: 26444575502     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi233     Document Type: Article

References (92)

1. Pan, Q., Shai, O., Misquitta, C., Zhang, W., Saltzman, A.L., Mohammad, N., Babak, T., Siu, H., Hughes, T.R., Morris, Q.D. [i#et al.#1i] (2004) Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform. [i#Mol. Cell#1i], [b#16#1b], 929-941.
2. Smith, C.W. and Valcarcel, J. (2000) Alternative pre-mRNA splicing: The logic of combinatorial control. [i#Trends Biochem. Sci.#1i], [b#25#1b], 381-388.
3. Black, D.L. (2003) Mechanisms of alternative pre-messenger RNA splicing. [i#Annu. Rev. Biochem.#1i], [b#72#1b], 291-336.
4. Park, J.W., Parisky, K., Celotto, A.M., Reenan, R.A. and Graveley, B.R. (2004) Identification of alternative splicing regulators by RNA interference in [i#Drosophila. Proc. Natl Acad. Sci. USA#1i], [b#101#1b], 15974-15979.
5. Yeo, G., Holste, D., Kreiman, G. and Burge, C.B. (2004) Variation in alternative splicing across human tissues. [i#Genome Biol.#1i], [b#5#1b], R74.
6. Honda, K., Yamada, T., Seike, M., Hayashida, Y., Idogawa, M., Kondo, T., Ino, Y. and Hirohashi, S. (2004) Alternative splice variant of actinin-4 in small cell lung cancer. [i#Oncogene#1i], [b#23#1b], 5257-5262.
7. de Graaf, K., Hekerman, P., Spelten, O., Herrmann, A., Packman, L.C., Bussow, K., Muller-Newen, G. and Becker, W. (2004) Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich domain: phosphorylation by DYRK1A and colocalization with splicing factors. [i#J. Biol. Chem.#1i], [b#279#1b], 4612-4624.
8. Venables, J.P. (2002) Alternative splicing in the testes. [i#Curr. Opin. Genet. Dev.#1i], [b#12#1b], 615-619.
9. Stoss, O., Stoilov, P., Hartmann, A.M., Nayler, O. and Stamm, S. (1999) The [i#in vivo#1i] minigene approach to analyze tissue-specific splicing. [i#Brain Res. Brain Res. Protoc.#1i], [b#4#1b], 383-394.
10. Eperon, L.P., Graham, I.R., Griffiths, A.D. and Eperon, I.C. (1988) Effects of RNA secondary structure on alternative splicing of pre-mRNA: is folding limited to a region behind the transcribing RNA polymerase? [i#Cell#1i], [b#54#1b], 393-401.
11. Roberts, G.C., Gooding, C., Mak, H.Y., Proudfoot, N.J. and Smith, C.W. (1998) Co-transcriptional commitment to alternative splice site selection. [i#Nucleic Acids Res.#1i], [b#26#1b], 5568-5572.
12. Buratti, E. and Baralle, F.E. (2004) Influence of RNA secondary structure on the pre-mRNA splicing process. [i#Mol. Cell. Biol.#1i], [b#24#1b], 10505-10514.
13. Ibrahim el, C., Schaal, T.D., Hertel, K.J., Reed, R. and Maniatis, T. (2005) From the cover: Serine/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers. [i#Proc. Natl Acad. Sci. USA#1i], [b#102#1b], 5002-5007.
14. Kornblihtt, A.R., de la Mata, M., Fededa, J.P., Munoz, M.J. and Nogues, G. (2004) Multiple links between transcription and splicing. [i#RNA#1i], [b#10#1b], 1489-1498.
15. Zorio, D.A. and Bentley, D.L. (2004) The link between mRNA processing and transcription: Communication works both ways. [i#Exp. Cell Res.#1i], [b#296#1b], 91-97.
16. Ghosh, S. and Garcia-Blanco, M.A. (2000) Coupled [i#in vitro#1i] synthesis and splicing of RNA polymerase II transcripts. [i#RNA#1i], [b#6#1b] 1325-1334.
17. Bourgeois, C.F., Lejeune, F. and Stevenin, J. (2004) Broad specificity of SR (serine/arginine) proteins in the regulation of alternative splicing of pre-messenger RNA. [i#Prog. Nucleic Acid Res. Mol. Biol.#1i], [b#78#1b], 37-88.
18. Sanford, J.R., Longman, D. and Caceres, J.F. (2003) Multiple roles of the SR protein family in splicing regulation. [i#Prog. Mol. Subcell. Biol.#1i], [b#31#1b], 33-58.
19. Huang, Y. and Steitz, J.A. (2005) SRprises along a messenger's journey. [i#Mol. Cell#1i], [b#17#1b], 613-615.
20. Hertel, K.J. and Graveley, B.R. (2005) RS domains contact the pre-mRNA throughout spliceosome assembly. [i#Trends Biochem. Sci.#1i], [b#30#1b], 115-118.
21. Venables, J.P., Elliott, D.J., Makarova, O.V., Makarov, E.M., Cooke, H.J. and Eperon, I.C. (2000) RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing. [i#Hum. Mol. Genet.#1i], [b#9#1b], 685-694.
22. Jin, P., Fu, G.K., Wilson, A.D., Yang, J., Chien, D., Hawkins, P.R., Au-Young, J. and Stuve, L.L. (2004) PCR isolation and cloning of novel splice variant mRNAs from known drug target genes. [i#Genomics#1i], [b#83#1b] 566-571.
23. Le Fourn, V., Ferrand, M. and Franc, J.L. (2004) Differential expression of thyroperoxidase mRNA splice variants in human thyroid tumors. [i#Biochim. Biophys. Acta#1i], [b#1689#1b], 134-141.
24. Sorek, R., Shamir, R. and Ast, G. (2004) How prevalent is functional alternative splicing in the human genome? [i#Trends Genet.#1i], [b#20#1b], 68-71.
25. Venables, J.P., Dalgliesh, C., Paronetto, M.P., Skirt, L., Thornton, J.K., Saunders, P.T., Sette, C., Jones, K.T. and Elliott, D.J. (2004) SIAH1 targets the alternative splicing factor T-STAR for degradation by the proteasome. [i#Hum. Mol. Genet.#1i], [b#13#1b], 1525-1534.
26. Venables, J.P., Vernet, C., Chew, S.L., Elliott, D.J., Cowmeadow, R.B., Wu, J., Cooke, H.J., Artzt, K. and Eperon, I.C. (1999) T-STAR/ETOILE: A novel relative of SAM68 that interacts with an RNA-binding protein implicated in spermatogenesis. [i#Hum. Mol. Genet.#1i], [b#8#1b], 959-969.
27. Elliott, D.J., Venables, J.P., Newton, C.S., Lawson, D., Boyle, S., Eperon, I.C. and Cooke, H.J. (2000) An evolutionarily conserved germ cell-specific hnRNP is encoded by a retrotransposed gene. [i#Hum. Mol. Genet.#1i], [b#9#1b], 2117-2124.
28. Li, Y. and Blencowe, B.J. (1999) Distinct factor requirements for exonic splicing enhancer function and binding of U2AF to the polypyrimidine tract. [i#J. Biol. Chem.#1i], [b#274#1b], 35074-35079.
29. Tacke, R., Tohyama, M., Ogawa, S. and Manley, J.L. (1998) Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. [i#Cell#1i] [b#93#1b], 139-148.
30. Fairbrother, W.G., Yeh, R.F., Sharp, P.A. and Burge, C.B. (2002) Predictive identification of exonic splicing enhancers in human genes. [i#Science#1i], [b#297#1b], 1007-1013.
31. Cavaloc, Y., Bourgeois, C.F., Kister, L. and Stevenin, J. (1999) The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. [i#RNA#1i], [b#5#1b], 468-483.
32. Burd, C.G. and Dreyfuss, G. (1994) Conserved structures and diversity of functions of RNA-binding proteins. [i#Science#1i], [b#265#1b], 615-621.
33. Kashima, T. and Manley, J.L. (2003) A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. [i#Nat. Genet.#1i], [b#34#1b] 460-463.
34. Caputi, M. and Zahler, A.M. (2001) Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/ H′/F/2H9 family. [i#J. Biol. Chem.#1i], [b#276#1b], 43850-43859.
35. Expert-Bezancon, A., Sureau, A., Durosay, P., Salesse, R., Groeneveld, H., Lecaer, J.P. and Marie, J. (2004) hnRNP A1 and the SR proteins ASF/ SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B. [i#J. Biol. Chem.#1i], [b#279#1b], 38249-38259.
36. Rooke, N., Markovtsov, V., Cagavi, E. and Black, D.L. (2003) Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1. [i#Mol. Cell. Biol.#1i], [b#23#1b], 1874-1884.
37. Marchand, V., Mereau, A., Jacquenet, S., Thomas, D., Mougin, A., Gattoni, R., Stevenin, J. and Branlant, C. (2002) A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. [i#J. Mol. Biol.#1i], [b#323#1b], 629-652.
38. Eperon, I.C., Makarova, O.V., Mayeda, A., Munroe, S.H., Caceres, J.F., Hayward, D.G. and Krainer, A.R. (2000) Selection of alternative 5′ splice sites: Role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1. [i#Mol. Cell. Biol.#1i], [b#20#1b], 8303-8318.
39. Bourgeois, C.F., Popielarz, M., Hildwein, G. and Stevenin, J. (1999) Identification of a bidirectional splicing enhancer: Differential involvement of SR proteins in 5′ or 3′ splice site activation. [i#Mol. Cell. Biol.#1i], [b#19#1b], 7347-7356.
40. Beil, B., Screaton, G. and Stamm, S. (1997) Molecular cloning of htra2-beta-1 and htra2-beta-2, two human homologs of tra-2 generated by alternative splicing. [i#DNA Cell Biol.#1i], [b#16#1b], 679-690.
41. Chen, X., Guo, L., Lin, W. and Xu, P. (2003) Expression of Tra2beta isoforms is developmentally regulated in a tissue- and temporal-specific pattern. [i#Cell Biol. Int.#1i], [b#27#1b], 491-496.
42. Nayler, O., Cap, C. and Stamm, S. (1998) Human transformer-2-beta gene (SFRS10): Complete nucleotide sequence, chromosomal localization, and generation of a tissue-specific isoform. [i#Genomics#1i], [b#53#1b], 191-202.
43. Maquat, L.E. (2004) Nonsense-mediated mRNA decay: Splicing, translation and mRNP dynamics. [i#Nat. Rev. Mol. Cell Biol.#1i], [b#5#1b], 89-99.
44. Pacheco, T.R., Gomes, A.Q., Barbosa-Morais, N.L., Benes, V., Ansorge, W., Wollerton, M., Smith, C.W., Valcarcel, J. and Carmo-Fonseca, M. (2004) Diversity of vertebrate splicing factor U2AF35: Identification of alternatively spliced U2AF1 mRNAS. [i#J. Biol. Chem.#1i], [b#279#1b], 27039-27049.
45. Kim, Y.H., Choi, C.Y., Lee, S.J., Conti, M.A. and Kim, Y. (1998) Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. [i#J. Biol. Chem.#1i], [b#273#1b], 25875-25879.
46. Faustino, N.A. and Cooper, T.A. (2003) Pre-mRNA splicing and human disease. [i#Genes Dev.#1i], [b#17#1b], 419-437.
47. Wang, Y., Wang, J., Gao, L., Lafyatis, R., Stamm, S. and Andreadis, A. (2005) Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1. [i#J. Biol. Chem.#1i], [b#280#1b], 14230-14239.
48. Jiang, Z., Tang, H., Havlioglu, N., Zhang, X., Stamm, S., Yan, R. and Wu, J.Y. (2003) Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta. [i#J. Biol. Chem.#1i], [b#278#1b], 18997-19007.
49. Soret, J. and Tazi, J. (2003) Phosphorylation-dependent control of the pre-mRNA splicing machinery. [i#Prog. Mol. Subcell. Biol.#1i], [b#31#1b], 89-126.
50. Shin, C., Feng, Y. and Manley, J.L. (2004) Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. [i#Nature#1i], [b#427#1b] 553-558.
51. Du, C., McGuffin, M.E., Dauwalder, B., Rabinow, L. and Mattox, W. (1998) Protein phosphorylation plays an essential role in the regulation of alternative splicing and sex determination in [i#Drosophila. Mol. Cell#1i] [b#2#1b], 741-750.
52. Yun, C.Y., Velazquez-Dones, A.L., Lyman, S.K. and Fu, X.D. (2003) Phosphorylation-dependent and -independent nuclear import of RS domain-containing splicing factors and regulators. [i#J. Biol. Chem.#1i], [b#278#1b], 18050-18055.
53. Stoilov, P., Daoud, R., Nayler, O. and Stamm, S. (2004) Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA. [i#Hum. Mol. Genet.#1i], [b#13#1b], 509-524.
54. Andreadis, A. (2005) Tau gene alternative splicing: Expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. [i#Biochim. Biophys. Acta.#1i], [b#1739#1b], 91-103.
55. Nasim, M.T., Chernova, T.K., Chowdhury, H.M., Yue, B.G. and Eperon, I.C. (2003) HnRNP G and Tra2beta: Opposite effects on splicing matched by antagonism in RNA binding. [i#Hum. Mol. Genet.#1i], [b#12#1b], 1337-1348.
56. Hofmann, Y. and Wirth, B. (2002) hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1. [i#Hum. Mol. Genet.#1i], [b#11#1b], 2037-2049.
57. Hofmann, Y., Lorson, C.L., Stamm, S., Androphy, E.J. and Wirth, B. (2000) Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). [i#Proc. Natl Acad. Sci. USA#1i], [b#97#1b], 9618-9623.
58. Buratti, E., Baralle, M., De Conti, L., Baralle, D., Romano, M., Ayala, Y.M. and Baralle, F.E. (2004) hnRNP H binding at the 5′ splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSHbeta genes. [i#Nucleic Acids Res.#1i], [b#32#1b], 4224-4236.
59. Chou, M.Y., Rooke, N., Turck, C.W. and Black, D.L. (1999) hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. [i#Mol. Cell. Biol.#1i], [b#19#1b], 69-77.
60. Grabowski, P.J. (2004) A molecular code for splicing silencing: configurations of guanosine-rich motifs. [i#Biochem. Soc. Trans.#1i], [b#32#1b], 924-927.
61. Zahler, A.M., Damgaard, C.K., Kjems, J. and Caputi, M. (2004) SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing. [i#J. Biol. Chem.#1i], [b#279#1b], 10077-10084.
62. Hou, V.C., Lersch, R., Gee, S.L., Ponthier, J.L., Lo, A.J., Wu, M., Turck, C.W., Koury, M., Krainer, A.R., Mayeda, A. [i#et al.#1i] (2002) Decrease in hnRNP A/B expression during erythropoiesis mediates a pre-mRNA splicing switch. [i#EMBO J.#1i], [b#21#1b], 6195-6204.
63. Hanamura, A., Caceres, J.F., Mayeda, A., Franza, B.R., Jr and Krainer, A.R. (1998) Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. [i#RNA#1i], [b#4#1b], 430-444.
64. Kamma, H., Portman, D.S. and Dreyfuss, G. (1995) Cell type-specific expression of hnRNP proteins. [i#Exp. Cell Res.#1i], [b#221#1b], 187-196.
65. Matsui, M., Horiguchi, H., Kamma, H., Fujiwara, M., Ohtsubo, R. and Ogata, T. (2000) Testis- and developmental stage-specific expression of hnRNP A2/B1 splicing isoforms, B0a/b. [i#Biochim. Biophys. Acta#1i], [b#1493#1b], 33-40.
66. Moilanen, A.M., Karvonen, U., Poukka, H., Janne, O.A. and Palvimo, J.J. (1998) Activation of androgen receptor function by a novel nuclear protein kinase. [i#Mol. Biol. Cell#1i], [b#9#1b], 2527-2543.
67. Kondo, S., Lu, Y., Debbas, M., Lin, A.W., Sarosi, I., Itie, A., Wakeham, A., Tuan, J., Saris, C., Elliott, G. [i#et al.#1i] (2003) Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1). [i#Proc. Natl Acad. Sci. USA#1i], [b#100#1b], 5431-5436.
68. Kim, E.J., Park, J.S. and Um, S.J. (2002) Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family [i#in vivo. J. Biol. Chem.#1i], [b#277#1b], 32020-32028.
69. Moller, A., Sirma, H., Hofmann, T.G., Rueffer, S., Klimczak, E., Droge, W., Will, H. and Schmitz, M.L. (2003) PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. [i#Cancer Res.#1i], [b#63#1b], 4310-4314.
70. Begley, D.A., Berkenpas, M.B., Sampson, K.E. and Abraham, I. (1997) Identification and sequence of human PKY, a putative kinase with increased expression in multidrug-resistant cells, with homology to yeast protein kinase Yak1. [i#Gene#1i], [b#200#1b], 35-43.
71. Rochat-Steiner, V., Becker, K., Micheau, O., Schneider, P., Burns, K. and Tschopp, J. (2000) FIST/HIPK3: A Fas/FADD-interacting serine/ threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation. [i#J. Exp. Med.#1i], [b#192#1b], 1165-1174.
72. Curtin, J.F. and Cotter, T.G. (2004) JNK regulates HIPK3 expression and promotes resistance to Fas-mediated apoptosis in DU 145 prostate carcinoma cells. [i#J. Biol. Chem.#1i], [b#279#1b], 17090-17100.
73. Chalfant, C.E., Ogretmen, B., Galadari, S., Kroesen, B.J., Pettus, B.J. and Hannun, Y.A. (2001) FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase 1. [i#J. Biol. Chem.#1i], [b#276#1b], 44848-44855.
74. Wu, J.Y., Tang, H. and Havlioglu, N. (2003) Alternative pre-mRNA splicing and regulation of programmed cell death. [i#Prog. Mol. Subcell. Biol.#1i], [b#31#1b], 153-185.
75. Zhang, D., Li, K., Erickson-Miller, C.L., Weiss, M. and Wojchowski, D.M. (2005) DYRK gene structure and erythroid-restricted features of DYRK3 gene expression. [i#Genomics#1i], [b#85#1b], 117-130.
76. Sakashita, E., Tatsumi, S., Werner, D., Endo, H. and Mayeda, A. (2004) Human RNPS1 and its associated factors: A versatile alternative pre-mRNA splicing regulator [i#in vivo. Mol. Cell. Biol.#1i], [b#24#1b], 1174-1187.
77. Daoud, R., Da Penha Berzaghi, M., Siedler, F., Hubener, M. and Stamm, S. (1999) Activity-dependent regulation of alternative splicing patterns in the rat brain. [i#Eur. J. Neurosci.#1i], [b#11#1b], 788-802.
78. Caputi, M., Mayeda, A., Krainer, A.R. and Zahler, A.M. (1999) hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing. [i#EMBO J.#1i], [b#18#1b], 4060-4067.
79. Del Gatto-Konczak, F., Bourgeois, C.F., Le Guiner, C., Kister, L., Gesnel, M.C., Stevenin, J. and Breathnach, R. (2000) The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5′ splice site. [i#Mol. Cell. Biol.#1i], [b#20#1b], 6287-6299.
80. Rabilloud, T. (1999) Silver staining of 2-D electrophoresis gels. [i#Methods Mol. Biol.#1i], [b#112#1b], 297-305.
81. Cavusoglu, N., Brand, M., Tora, L. and Van Dorsselaer, A. (2003) Novel subunits of the TATA binding protein free TAFII-containing transcription complex identified by matrix-assisted laser desorption/ionization-time of flight mass spectrometry following one-dimensional gel electrophoresis. [i#Proteomics#1i], [b#3#1b], 217-223.
82. Elliott, D.J., Bourgeois, C.F., Klink, A., Stevenin, J. and Cooke, H.J. (2000) A mammalian germ cell-specific RNA-binding protein interacts with ubiquitously expressed proteins involved in splice site selection. [i#Proc. Natl Acad. Sci. USA#1i], [b#97#1b], 5717-5722.
83. Nissim-Rafinia, M., Aviram, M., Randell, S.H., Shushi, L., Ozeri, E., Chiba-Falek, O., Eidelman, O., Pollard, H.B., Yankaskas, J.R. and Kerem, B. (2004) Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation. [i#EMBO Rep.#1i], [b#5#1b], 1071-1077.
84. Stamm, S., Casper, D., Hanson, V. and Helfman, D.M. (1999) Regulation of the neuron-specific exon of clathrin light chain B. [i#Brain Res. Mol. Brain Res.#1i], [b#64#1b], 108-118.
85. Chen, X., Huang, J., Li, J., Han, Y., Wu, K. and Xu, P. (2004) Tra2beta1 regulates P19 neuronal differentiation and the splicing of FGF-2R and GluR-B minigenes. [i#Cell. Biol. Int.#1i], [b#28#1b], 791-799.
86. Seong, J.Y., Han, J., Park, S., Wuttke, W., Jarry, H. and Kim, K. (2002) Exonic splicing enhancer-dependent splicing of the gonadotropin-releasing hormone premessenger ribonucleic acid is mediated by tra2alpha, a 40-kilodalton serine/arginine-rich protein. [i#Mol. Endocrinol.#1i], [b#16#1b], 2426-2438.
87. Young, P.J., DiDonato, C.J., Hu, D., Kothary, R., Androphy, E.J. and Lorson, C.L. (2002) SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1. [i#Hum. Mol. Genet.#1i], [b#11#1b], 577-587.
88. Brichta, L., Hofmann, Y., Hahnen, E., Siebzehnrubl, F.A., Raschke, H., Blumcke, I., Eyupoglu, I.Y. and Wirth, B. (2003) Valproic acid increases the SMN2 protein level: A well-known drug as a potential therapy for spinal muscular atrophy. [i#Hum. Mol. Genet.#1i], [b#12#1b], 2481-2489.
89. Kiryu-Seo, S., Matsuo, N., Wanaka, A., Ogawa, S., Tohyama, M. and Kiyama, H. (1998) A sequence-specific splicing activator, tra2beta, is up-regulated in response to nerve injury. [i#Brain Res. Mol. Brain Res.#1i] [b#62#1b], 220-223.
90. Daoud, R., Mies, G., Smialowska, A., Olah, L., Hossmann, K.A. and Stamm, S. (2002) Ischemia induces a translocation of the splicing factor tra2-beta 1 and changes alternative splicing patterns in the brain. [i#J. Neurosci.#1i], [b#22#1b], 5889-5899.
91. Stamm, S. (2002) Signals and their transduction pathways regulating alternative splicing: A new dimension of the human genome. [i#Hum. Mol. Genet.#1i], [b#11#1b], 2409-2416.
92. Tsukamoto, Y., Matsuo, N., Ozawa, K., Hori, O., Higashi, T., Nishizaki, J., Tohnai, N., Nagata, I., Kawano, K., Yutani, C. [i#et al.#1i] (2001) Expression of a novel RNA-splicing factor, RA301/Tra2beta, in vascular lesions and its role in smooth muscle cell proliferation. [i#Am. J. Pathol.#1i], [b#158#1b], 1685-1694.